Unlocking stem cells’ full potential for treating multiple sclerosis

River D'Almeida, Ph.D
5 min readJan 28, 2022

Highs, lows and future opportunities from OHRI’s MESEMS trial

Image courtesy of author

Article via Signals Blog

Cells that are programmed to protect can sometimes go rogue, as is the case with multiple sclerosis, or MS. Overactive immune cells mistakenly target the tissues of the brain, spinal cord and optic nerves, igniting inflammatory flare-ups…

--

--

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.